Discover 1,271 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,271
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
for
IgA Nephropathy
Location: Glendale AZ, San Bernardino CA, Orange CA,
Sponsor: Calliditas Therapeutics AB
Sex: All
Age: 18+
Code: NCT06712407
Recruiting
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Location: Glendale AZ, Mesa AZ, San Diego CA, Tarzana CA,
Sponsor: Olatec Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05658575
Phase2, Phase3, Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for
Sjögren's Syndrome
Location: Glendale AZ, Avondale AZ, Gilbert AZ, Flagstaff AZ,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06747949
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: Glendale AZ, Mesa AZ, Albuquerque NM, Oklahoma City OK,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06807424
Phase3, Recruiting
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
for
Dermatomyositis, Polymyositis
Location: Glendale AZ, Houston TX
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06698796
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
for
Myositis
Location: Glendale AZ, Phoenix AZ, Scottsdale AZ, Los Angeles CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05895786
Phase3, Recruiting
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
for
Active Rheumatoid Arthritis
Location: Glendale AZ, Gilbert AZ, Tucson AZ, Tustin CA,
Sponsor: Elevara Medicines Limited
Sex: All
Age: 18 - 70+
Code: NCT07409103
Phase2, Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
for
Radiographic Axial Spondyloarthritis
Location: Glendale AZ, Chandler AZ, Gilbert AZ, Flagstaff AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 70+
Code: NCT07133633
Phase2, Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for
Gout
Location: Glendale AZ, Mesa AZ, Gilbert AZ, Tucson AZ,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089875
Phase3, Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for
Tophaceous Gout
Location: Glendale AZ, Mesa AZ, Gilbert AZ, Tucson AZ,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089888
Phase3, Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
for
Psoriatic Arthritis
Location: Phoenix AZ, Chandler AZ, La Mesa CA, Fountain Valley CA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06671483
Phase3, Recruiting
New
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
for
Obesity, Overweight, Chronic Weight Management,
Location: Phoenix AZ, San Antonio TX, Austin TX, Evansville IN,
Sponsor: Ascletis Pharma (China) Co., Limited
Sex: All
Age: 18+
Code: NCT07743450
Phase3, Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Glendale AZ, Las Vegas NV, Walnut Creek CA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase2, Phase3, Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Glendale AZ, Bullhead City AZ, Fountain Valley CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase3, Recruiting
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
for
Immune Thrombocytopenia
Location: Glendale AZ, Los Angeles CA, Lone Tree CO, Fairfax VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07104565
Phase2, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Glendale AZ, Goodyear AZ, Chandler AZ, St. George UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Glendale AZ, Phoenix AZ, Scottsdale AZ,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Glendale AZ, Newport Beach CA, Farmington NM,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC